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AbsTrACT
Objective To investigate the brain-derived neurotrophic 
factor (BDNF) and cognitive response to a short bout of 
high-intensity aerobic exercise in older adults with mild 
cognitive impairment (MCI).
Methods Participants were randomised to one of two 
testing schedules, completing either a standardised 
exercise test (group A) or a resting control condition 
(group B). Blood sampling and cognitive measures 
(visuospatial learning and memory, sustained attention 
and executive function) were collected at baseline (T1) and 
postintervention (T2). An additional measurement of study 
outcomes was collected after exercise (T3) in group B only.
results 64 participants (female 53.2%, mean age 
70.5±6.3 years) with MCI were recruited. From T1 to T2, 
serum BDNF (sBDNF) concentration increased in group 
A (n=35) (median (Md) 4564.61±IQR 5737.23 pg/mL to 
Md 5173.27±5997.54 pg/mL) and decreased in group B 
(Md 4593.74±9558.29 pg/mL to Md 3974.66±3668.22 
pg/mL) (between-group difference p=0.024, effect size 
r=0.3). The control group made fewer errors on the 
sustained attention task compared with the exercise group 
(p=0.025). Measures of visuospatial learning and memory 
or executive function did not change significantly between 
groups.
Conclusion This study is the first to show that a short 
bout of high-intensity aerobic exercise increases peripheral 
sBDNF in a population with MCI. However, acute exercise 
did not improve cognitive performance.
InTrOduCTIOn
Mild cognitive impairment (MCI) is regarded 
as a clinical prodrome to Alzheimer’s disease 
(AD) and other dementias, affecting approx-
imately 15%–20% of people over the age 
of 65,1 with 10%–15% of people with MCI 
progressing to dementia per year.2 With 
the ongoing challenges in developing 
disease-modifying drugs, research into 
non-pharmacological strategies such as exer-
cise, to prevent dementia or treat cognitive 
decline has gained increasing importance. A 
recent update to the American Academy of 
Neurology practice guideline on MCI now 
includes a recommendation for regular exer-
cise as part of overall disease management.3
A significant body of work has investigated 
the effects of acute exercise on cognition. 
Meta-analytical reviews report an overall 
small positive effect on cognitive perfor-
mance following acute exercise (mean effect 
0.10–0.20), especially in areas of prefrontal 
cortex-dependent cognition.4–6 However, the 
underlying neurobiological basis of these 
results has received less attention.
Brain-derived neurotrophic factor (BDNF), 
a member of the neurotrophin family, plays 
a predominant role in neuronal plasticity7 
and has been shown to decrease progres-
sively with age,8 9 with attenuated loss and a 
corresponding decrease in cognitive func-
tion in MCI cohorts compared with elderly 
controls.10–12 Studies in both animal models 
and human subjects have described a 
number of neurobiological changes after an 
acute bout of exercise13 and recent evidence 
What are the new findings?
 ► A short bout of high-intensity exercise increased se-
rum brain-derived neurotrophic factor (sBDNF) in a 
mild cognitive impairment (MCI) cohort.
 ► While high-intensity interventions were feasible in 
this patient group, significant improvements were 
not observed in cognitive performance.
How might it impact on clinical practice?
 ► Further research is needed to establish if acute 
exercises increase resting sBDNF concentration. 
However, exercise training may be a potential strat-
egy to address the declining BDNF profile in an MCI 
population.
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Figure 1 Study design and schedule of outcome 
assessments.
postulates BDNF as a mediator of the acute exercise-cog-
nitive relationship in healthy cohorts.14
The transitional phase of MCI along the cognitive 
continuum presents an opportunity for targeted inter-
ventions such as the exercise-induced upregulation of 
BDNF, which may help slow the rate of cognitive decline. 
As chronic exercise is the cumulative result of regular 
bouts of acute exercise, understanding the neurobio-
logical effects of varying acute exercise paradigms is an 
integral part of building a comprehensive understanding 
of the long-term effects of exercise on cognitive func-
tion.13 This information will help determine the optimal 
prescription of acute and chronic exercise and add to 
the emerging research that supports the role of exercise 
as a natural therapeutic tool to treat cognitive decline in 
older adults with MCI.
The aim of this study was to examine the effect of a 
short bout of high-intensity aerobic exercise on serum 
BDNF (sBDNF) and cognitive performance in indi-
viduals with MCI. The working hypothesis was that a 
short bout of high-intensity exercise would significantly 
increase sBDNF and cognitive performance compared 
with a resting control condition.
MeTHOds
study design
Participants were randomised to one of two testing 
schedules (figure 1) using a computer-generated rando-
misation list generated by a researcher independent of 
the study. Treatment allocation was concealed from the 
investigator. Group A represented the exercise condi-
tion while group B was designed to act as the control 
condition. Outcome measurements were collected at T1 
(baseline) and T2 (after the exercise condition in group 
A and after a resting control condition for group B), 
with T3 measurements (after exercise) only collected in 
group B.
Patient and Public Involvement (PPI)
As no funds or time were allocared for PPI, partici-
pants were unable to be involved in study design stages. 
However, participants have been involved in the dissem-
ination.
Participants
Inclusion and exclusion criteria
Participants were screened and recruited from a network 
of memory clinics (n=38) and through community 
recruitment (n=26).15 16 Details of the study inclusion 
and exclusion criteria have been published in the Neuro-
Exercise study protocol.16 To summarise, participants 
had a diagnosis of amnestic MCI due to AD according to 
the National Institute on Aging and Alzheimer’s Associ-
ation criteria,17 scored 18–26 on the Montreal Cognitive 
Assessment (MoCA)18 and were classified as having 
memory decline but not dementia (Clinical Dementia 
Rating global score=0.5). Participants met the following 
inclusion criteria: ECG without significant abnormalities, 
and medical clearance to undergo a symptom-limited 
cardiopulmonary exercise test (CPET). Participants were 
deemed ineligible if they had a diagnosis of AD or other 
type of dementia; any major psychiatric disorder; unstable 
cardiac, renal, lung, liver or other severe chronic disease; 
or engagement in moderate-intensity aerobic exercise 
training for more than 30 min, three times per week, 
during the past 2 years.
study outcomes
Data collection and study interventions were conducted 
at the Wellcome Trust-Health Research Board Clinical 
Research Facility in Dublin. Ethical approval was granted 
from Tallaght Hospital and St James’ Hospital Joint 
Research and Ethics Committee (REC) and the RECs 
of referring sites. Due to limited study personnel, the 
outcome assessor was not blinded to intervention group. 
All study outcomes were collected in a non-fasting state 
between the hours of 09:00 and 15:00.
Blood sampling
Participants completed a 10 min resting period prior 
to baseline blood sampling (T1), with postintervention 
blood samples collected within a 10 min period following 
each experimental condition. Serum collection tubes 
were inverted five times and allowed to coagulate at room 
temperature before being centrifuged at 1300×g for 10 
min at 4°C. The resulting serum was removed, aliquoted 
and stored at −80°C pending laboratory analysis. Samples 
and standards were analysed using commercially avail-
able BDNF DuoSet ELISA development systems kit 
(R&D Systems Europe, Oxon, UK) in accordance with 
the manufacturer’s instruction. Standard curve was 
constructed and concentration of BDNF in samples was 
calculated by extrapolation from these curves with results 
expressed in pg/mL.
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Table 1 Participant demographics by study group
Variable
Group A: 
Exercise
n=35
Group B: 
Control
n=29 P value
Gender (M/F) 13/22 17/12 0.14
Age (years) 71.7 (5.3) 69.0 (7.2) 0.09
Education (years) 12.5 (3.0) 14.0 (3.2) 0.07
MoCA 21.6 (2.5) 22.4 (2.6) 0.24
BMI (kg/m2) 27.44 (4.49) 26.14 (4.21) 0.23
VO
2
max (mL/kg/
min)
17.77 (5.15) 21.35 (4.85) 0.002*
Data are presented as mean±SD for normally distributed data and 
as median ±IQR for non-normally distributed data. Note statistical 
significance.
*P<0.05.
BDI, body mass index; MoCa, Montreal Cognitive Assessment; 
VO
2
, oxygen consumption.
Cognitive performance
Cognitive tests were administered as per standardised 
test instructions and included the Cambridge Neuropsy-
chological Test Automated Battery (CANTAB) Paired 
Associates Learning (PAL) task, a measure of visuospa-
tial learning and memory which was considered the 
primary cognitive outcome. CANTAB PAL is regarded 
as a visuospatial memory task, highly sensitive to the 
memory impairments characteristic in prodromal AD 
that assesses visual memory and new learning through 
the testing of conditional learning of pattern–location 
associations.19 The Sustained Attention to Response Task 
(SART), a computerised Go-No-Go paradigm measuring 
sustained attention, and the Stroop Neuropsychological 
Screening Test (Stroop) measuring executive function 
were measured as secondary cognitive outcomes. Testing 
took approximately 30 min to complete.
Intervention
Participants performed a graded CPET to volitional 
exhaustion as per WHO protocol.20 The test was 
performed on a standard COSMED cycle ergometer with 
oxygen consumption (VO
2
) measured using the K4B22 
equipment (K4B22 User Manual, COSMED, Italy). ECG 
and blood pressure measurements were collected at rest 
and for the duration of the test. The protocol commenced 
with a 3 min warm-up of unloaded cycling followed by 
an incremental phase of cycling exercise during which 
the load increased by 25 W every 2 min until the test was 
terminated and a 3 min cool down period was performed. 
The test was terminated when three of the following 
criteria were met: clinical signs of exhaustion, respiratory 
quotient ≥1.10, reaching within 10 beats of the predicted 
heart rate max (220 age) or flattening of the VO
2
 uptake 
curve (≤110 mL increase during the last minute). The 
control condition in group B consisted of 30 min lying in 
a semirecumbent position.
Sample size
A recent meta-analytical review reported that an acute 
bout of exercise increased BDNF levels with a moderate 
effect size (Hedges’ g=0.46, SE=0.08, 95% CI 0.29 to 0.62, 
z=5.49, p<0.001).21 Using these values, with 0.05 signifi-
cance level and 80% power, 32 participants were required 
per arm to demonstrate an effect size of 0.46 in people 
with MCI.
statistical analysis
SPSS V.24 (SPSS) was used for analysis with statistical 
significance set at p<0.05. Kolmogorov-Smirnov test 
(p>0.05) and visual inspection of histogram and Q-Q 
plots were used to assess assumptions of normality on all 
baseline variables. In the case of non-normally distrib-
uted data, non-parametric tests were performed.
To standardise baseline data, BDNF data were exam-
ined for outliers, with measurements ±2 SDs removed 
from the mean excluded as per standard approach.22 
Following these criteria, n=9 were removed from further 
analysis. Second, relative change (%) in BDNF was 
reported consistent with published reports.23 24
For the primary analysis of study outcomes, between-
group differences between T1 and T2 were analysed 
using an independent samples t-test for normally 
distributed data and using a Mann-Whitney U test for 
non-normally distributed data. In the secondary anal-
ysis, Friedman’s test and analysis of variance were used 
to measure the change over time in study outcomes in 
group B. Wilcoxon signed-rank tests and paired sample 
t-tests were performed in post hoc analysis to determine 
the effect size and compare T1–T2, T2–T3 and T1–T3 in 
group B. As secondary analysis involved multiple compar-
isons, a Bonferroni correction was applied and alpha 
level was revised to 0.025. An exploratory analysis of sex 
differences in BDNF and cognition was performed.
resulTs
Participants were enrolled from 25 February 2016 and 
data collection for this study ended on 17 July 2017. Sixty-
four participants were enrolled and randomised to group 
A (n=35) or group B (n=29). Missing data included PAL 
at T1 (participant refusal to complete n=1), SART at T1 
(measurement error n=1), missed venepuncture at T2 
(n=1) and invalid Stroop T1–T3 (colour blindness n=2, 
incomplete record sheet n=2). Missing data were treated 
as missing at random and each missing observation 
removed from analysis.
Participant characteristics
Participant characteristics (age, sex, education, MoCA 
and body mass index) were similar between groups at base-
line (table 1). Participants had a mean age of 70.5 (±6.3) 
years, 53.2% female, mean MoCA score of 22.0 (±2.5) 
and the majority (n=38, 59.4%) were highly educated 
(>13 years). Cardiorespiratory (CR) fitness levels catego-
rised based on age and gender norms revealed a large 
proportion (n=54, 84.4%) were categorised as very poor 
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Figure 2 Boxplot showing between-group difference 
in serum BDNF (sBDNF) in response to a high-intensity 
exercise or resting control condition.
Table 2 Measurement parameters of exercise intensity and 
duration in the exercise condition for both groups
Group A 
n=35
Group B 
n=29 P value
Time (min:s) 09:11 
(03:63)
10:25 
(02:26)
0.11
Max watts (W
max
) 100 (50) 100 (50) 0.34
Max HR (HR
max
) 118 (20) 124 (21) 0.27
Peak lactate (mmol/L) 5.0 (4.8) 4.4 (2.7) 0.16
Lactate change (mmol/L) 2.9 (3.5) 2.8 (3.5) 0.33
Respiratory exchange 
ratio (RER)
1.06 
(0.12)
1.06 
(0.07)
0.95
(<20th percentile).25 Despite randomisation, CR fitness 
calculated using results of the CPET was significantly 
higher in group B (21.35±4.85 mL/kg/min) compared 
with group A (17.77±5.15 mL/kg/min).
There were no significant between-group differences 
in baseline measures of cognitive performance or 
sBDNF. Baseline sBDNF did not correlate with MoCA 
(r=0.10, p=0.46), Paired Associates Learning Total Errors 
Adjusted (PALTEA) (r=0.10, p=0.44) or age (r=−0.02, 
p=0.87). Baseline and postexercise BDNF did not 
correlate with CR fitness (VO
2
 max) (baseline r=−0.01, 
p=0.92; postexercise r=0.01, p=0.89). Baseline sBDNF 
concentration for male (Md 3699.52±6758.59 pg/mL1) 
and female (Md 5058.11±6280.08 pg/mL1) participants 
was comparable (p=0.224). Measurements of duration 
and intensity in the exercise condition did not show any 
significant between-group differences (table 2). There 
were no adverse events.
Primary analysis
Between-group difference in BDNF and cognitive performance
sBDNF concentration increased in group A (exercise 
condition) from T1 (Md 4564.61±5737.23 pg/mL1) 
to T2 (Md 5173.27±5997.54 pg/mL1) and decreased 
in group B (resting control condition) from T1 (Md 
4593.74±9558.29 pg/mL1) to T2 (Md 3974.66±3668.22 
pg/mL1) (p=0.024, Effect Size (ES)=0.3) (figure 2). The 
median % relative change in sBDNF from T1 to T2 in 
response to exercise in group A was 7.07% (±31.30%) 
and −13.3% (±22.49%) in response to a resting control 
condition in group B (p=0.06).
Surprisingly, SART commission error rate increased in 
group A (Md 0.50, n=34) and decreased in group B (Md 
−1.0, n=29) from T1 to T2, U=654.000, z=2.240, r=0.28. 
An acute bout of high-intensity exercise did not signifi-
cantly alter PALTEA, Stroop colour word score (CWS) or 
SART reaction time (RT) (table 3).
secondary analysis
Change over time within group B
Repeated measures analysis within group B indi-
cated a statistically significant difference in sBDNF 
across the three time points (p=0.005). sBDNF 
reduced significantly during the resting condition 
between T1 (Md=4593.74±9558.29 pg/mL1) and T2 
(Md=3974.66±3668.22 pg/mL1) (p=0.01, r=0.38), and 
increased significantly from T2 (Md=3974.66±3668.22 
pg/mL1) to T3 following completion of a short bout of 
high-intensity aerobic exercise (Md=4790.90±6713.17 
pg/mL1) (p=0.001, r=0.48). The relative change in 
sBDNF is consistent with the findings of the primary 
analysis, with the mean % relative change in sBDNF 
concentration from T2 to T3 (postexercise) in group B 
of 15.7% (±22.1%).
Stroop CWS (Wilks’ lambda=0.668, F(2,26)=6.461, 
p=0.005, multipartial η2=0.33) and SART RT (2, 
n=29)=0.036, p=0.005) changed significantly over 
time within group B. There were significant increases 
in Stroop CWS following participation in the exer-
cise condition from T1 (M=75.25±26.97) to T3 
(M=83.93±21.47) (mean increase=−8.67, 95% CI −13.55 
to −3.80) (p=0.001, ES 0.34), indicating improved perfor-
mance. SART RT reduced significantly in response to 
the control condition from T1 (Md 154.57 ms±78.90 
ms) to T2 (Md 123.61 ms±79.62 ms) (p=0.004, ES 0.37), 
with no significant change in SART commission errors. 
Additionally, PALTEA did not change significantly over 
time (2, n=29)=7.000, p=0.03) although a non-significant 
decrease in error rate was observed from T1 (Md 44±22) 
to T2 (Md 33±29) (z=−2.130, p=0.03, ES 0.27) and from 
T1 to T3 (Md=28±30) (z=−2.232, p=0.026, ES 0.29). 
Results are presented in table 4.
Sex differences in acute exercise BDNF and cognitive response
There was a significant difference in SART RT pre-to-
post exercise in female participants (Pre Md 156.14 
ms±83.31 ms to post Md 134.62 ms±69.86 ms) compared 
with male participants (Pre Md 130.08 ms±76.45 ms to 
post Md 136.77 ms±67.56 ms) (p=0.025, ES 0.28). There 
were no significant differences between male and female 
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Table 3 Effect of exercise on BDNF and cognitive outcomes
Variables Baseline (T1) Follow-up (T2)
Change within 
group P value Effect size
BDNF (pg/mL)
  Exercise 4642.51 (7065.08) 5308.17 (6355.73) 123.96 (2690.97) 0.07 n/a
  Control 5330.86 (10 346.65) 4477.95 (5002.88) −530.79 (1427.44)
BDNF (pg/mL) outliers excluded
  Exercise 4564.61 (5737.23) 5173.27 (5997.54) 135.86 (1709.74) 0.024* 0.3
  Control 4593.74 (9558.29) 3974.66 (3668.22) −530.79 (838.43)
CANTAB PALTEA
  Exercise 44 (30) 46 (23) .26 (10.29) 0.08 n/a
  Control 44 (22) 33 (29) −6 (15.3)
Stroop CWS
  Exercise 66.42 (28.51) 70.48 (30.66) 4.00 (16.00) 0.456 n/a
  Control 75.25 (26.97) 77.93 (27.42) 1.00 (13.00)
SART commission errors
  Exercise 2.5 (5) 4 (4) 0.5 (5) 0.025* 0.28
  Control 3 (4) 2 (3) −1 (3)
SART reaction time (ms)
  Exercise 142.04 (83.50) 128.07 (74.42) 4.84 (39.24) 0.055 n/a
  Control 154.57 (78.90) 123.61 (79.62) 27.66 (51.36)
Primary analysis: Between-group differences T1 and T2 time points. Data are presented for the exercise (group A) and control group 
(group B) as mean±SD for normally distributed data and as median±IQR for non-normally distributed data. P value represents within-group 
differences with statistical significance.
*P<0.05.
BDNF, brain-derived neurotrophic factor; CWS, colour word score; PALTEA, Paired Associates Learning Total Errors Adjusted; SART, 
Sustained Attention to Response Task; n/a, not applicable.
Table 4 Secondary analysis measuring change over time in study outcomes within group B
Variables Baseline T1 Postcontrol condition T2 Postexercise condition T3 P value
BDNF (pg/mL) outliers excluded 4593.74 (9558.29) 3974.66 (3668.22) 4790.90 (6713.17) 0.005*
CANTAB PALTEA 44 (22) 33 (29) 28 (30) 0.03
Stroop CWS 75.25 (26.97) 77.93 (27.42) 83.93 (21.47) 0.005*
SART commission errors 3 (4) 2 (3) 2 (3) 0.25
SART reaction time (ms) 154.57 (78.90) 123.61 (79.62) 142.07 (65.87) 0.005*
P value represents within group change over time with statistical significance.
Bonferroni correction applied and alpha level *P<0.025.
BDNF, brain-derived neurotrophic factor; CWS, colour word score; PALTEA, Paired Associates Learning Total Errors Adjusted; SART, 
Sustained Attention to Response Task.
participants in exercise BDNF response and other cogni-
tive measures.
dIsCussIOn
This study examined the changes in sBDNF concentra-
tion and cognitive performance in response to a short 
bout of high-intensity aerobic exercise in individuals with 
MCI. To the best of our knowledge, this is the first study 
to show that a short bout of high-intensity aerobic exer-
cise increases peripheral sBDNF in a population with 
MCI. The results support previous work in this area which 
has primarily focused on young healthy cohorts.22 26–33 
However, in the current study secondary analysis demon-
strated only modest within-group post exercise cognitve 
change.
The findings of the present study are consistent with 
previous studies that have reported increases in periph-
eral BDNF in response to acute exercise protocols in 
healthy adult cohorts22 26–33 and in clinical popula-
tions.34 35 To date, few studies have examined the effect 
of acute aerobic exercise on peripheral BDNF in older 
adults36–40 or MCI.41 However, a recent study by Tsai et 
al41 found an acute bout of 30 min of moderate-inten-
sity aerobic exercise significantly increased sBDNF levels 
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in a group (n=25) of older adults with amnestic MCI. In 
agreement, our findings indicate that older adults with 
MCI, despite being in the early stages of the neurodegen-
erative process, retain the ability to increase peripheral 
BDNF concentration following acute aerobic exercise of 
varying intensity and duration.
Across the literature, the % BDNF change in response 
to exercise varies widely in healthy and clinical popu-
lations, with an average increase of 60% reported in 
peripheral BDNF levels following acute exercise.23 42 The 
magnitude of BDNF change in response to exercise is 
dependent on blood lactate concentration, duration and 
intensity of exercise and is transient in nature.23 24 26 31 43–45 
The within-group sBDNF change in response to exercise 
observed in our results was 7.07% (group A) and 15.7% 
(group B). Studies of similar study design that examined 
comparable graded exercise protocols in healthy young 
cohorts22 26 27 and clinical populations36 46 reported higher 
% BDNF change in response to exercise (16%–30% rela-
tive change from baseline). Coelho et al36 examined the 
exercise BDNF response in 21 older adults with AD and 
18 healthy older adults and found significant increases 
in BDNF plasma levels in both groups (p=0.001; F=13.63; 
df=37) with a relative change of 22% and 16%, respec-
tively. Despite comparable performance of the exercise 
condition (duration and intensity) in both groups, group 
B demonstrated a higher % increase in sBDNF after 
exercise. In contrast to existing literature, the BDNF 
upregulation did not appear to be driven by lactate45 but 
may be explained by the significantly higher CR fitness 
observed in group B.
CR fitness in the present study cohort was low, with n=59 
(92.2%) of participants categorised as very poor (<20th 
percentile) or poor (20th–40th percentiles).25 While 
evidence supports strong associations between higher 
levels of CR fitness and cognitive function,47 48 the rela-
tionship between BDNF and CR fitness is unclear, with 
some studies reporting a positive association between the 
two immediately after exercise49 and others reporting 
an inverse relationship.50–52 A meta-analytical review by 
Dinoff et al42 reported significant associations between 
VO
2
 peak and effect sizes in studies measuring the effects 
of acute exercise on BDNF, indicating greater increases 
in peripheral BDNF after acute exercise in those with 
greater CR fitness. In the present study, we could not 
compare BDNF response in high and low-fit participants 
due to the homogeneity in the study sample but no 
correlation was found between CR fitness (V0
2
 max) and 
baseline sBDNF levels.
Despite the consistently reported positive effects of 
acute exercise on cognitive performance,14 28 53–55 the 
findings of the current study do not support the benefi-
cial effect of acute exercise on cognitive performance in 
MCI. In contrast, the resting control condition demon-
strated a decrease in sBDNF and improved performance 
on the SART, a task that activates the cortical and subcor-
tical attentional networks.56 While it is possible that the 
resting control condition may have reduced circulating 
cortisol levels similar to quiet meditation practice,57 58 the 
mechanisms underpinning the observed effect cannot be 
fully explained with further research required.
Recent meta-analytical reviews report that the BDNF 
and cognitive response to exercise may vary in a sex-de-
pendent manner.42 59 Subgroup analysis by Dinoff et al42 
revealed significant increase in BDNF after acute exer-
cise in males but not in females. In contrast, our findings 
did not reveal sex differences in BDNF response to acute 
exercise. However, we did observe sex differences in 
SART RT with females gaining significant improvement 
in RT following acute exercise compared with males. 
RTs are known to slow and become more variable with 
age, with significant sex differences reported in RT vari-
ability.60 Despite recent reports of sex differences in the 
cognitive response in executive function tasks to exer-
cise,59 we did not observe any sex differences in other 
cognitive measures in response to acute exercise.
The results of the present study should be viewed in 
the context of a number of potential limitations. First, 
peripheral measurement of BDNF is not without limita-
tions, as processes occurring centrally in the brain may 
not have a measurable influence on peripheral blood 
markers; nor may circulating BDNF have any influence 
on brain function within the time frame of this experi-
ment. Second, secondary analysis of change in cognitive 
performance (group B) demonstrated improvement 
in executive function after exercise. However, group 
B completed an additional measurement of cognitive 
measures (T3), thereby increasing the risk of type I error 
due to practice effects of repeated tests which may be an 
important confounder of these results.61 Finally, other 
factors that may mediate BDNF response to exercise were 
not examined. The BDNF val66met polymorphism, a 
genetic variant that occurs in 33% of the population, and 
the apolipoprotein E gene ε4 allele, the most prevalent 
genetic risk factor for late-onset AD, affect the expression 
of BDNF,62 alter susceptibility to neuropathology and 
may be an important consideration in understanding 
responders to exercise.63–67
COnClusIOns
The results of this study indicate that a single session 
of high-intensity exercise is feasible in an MCI cohort, 
enhances circulating sBDNF concentration but does not 
improve visuospatial learning and memory, sustained 
attention or executive function. This research adds to 
the literature which postulates that the impaired BDNF 
profile in MCI cohorts may be amenable to exercise 
training as a strategy to address the declining BDNF 
profile.
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